This virtual roundtable will explore the challenges and opportunities facing companies developing oncology and rare disease products during the COVID-19 pandemic. Parexel will be joined by Sara’s Cure, a Clear Cell Sarcoma patient advocacy group and charitable foundation.

The panelists will discuss:

  • Patient experiences of the pandemic
  • Patient perspectives on participating in research during the pandemic
  • Considerations for development strategy for oncology and rare disease programs at this time
  • Working with global health authorities for smoother start-up of research programs during COVID-19

Featured Speakers

Leslie DeVos

VP, Regulatory & Access
Parexel


Kristen Seamans

Patient Representative
Sara's Cure


Lennie Woods

Parent and Founder
Sara's Cure


Amy McKee, M.D.

Vice President, Regulatory Consulting Services
Parexel


NOW AVAILABLE ON-DEMAND

Register now for this webinar